FMED
Fidelity Disruptive Medicine ETF · NAS
- Category Equity
- Expense Ratio 0.5%
- Listing Date Jun 12, 2023
- Volume 3,676.0
- Market Cap (AUM) $52.14M
Performance
+0.29%
1W
+2.48%
1M
-2.19%
3M
+16.46%
6M
+1.37%
YTD
-3.81%
1Y
Top Holdings
-
Name
Symbol%Assets
- Boston Scientific CorporationBSX6.22%
- Fidelity Revere Street Trust Central Cash Collateral FundN/A4.25%
- UnitedHealth Group IncorporatedUNH4.24%
- Danaher CorporationDHR3.78%
- Centene CorporationCNC3.62%
- Intuitive Surgical, Inc.ISRG3.47%
- Insulet CorporationPODD3.15%
- Alnylam Pharmaceuticals, IncALNY3.06%
- Lifestance Health Group, Inc.LFST2.64%
- Regeneron Pharmaceuticals, Inc.REGN2.51%
Technical Analysis of FMED 2024-05-10
Overview:
In analyzing the technical indicators for FMED over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for informed deci...
Recent News & Updates
Page 1 of 1
previousnext